Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15

Oncogene

Volumn 25, Issue 1, 2006, Pages 79-90

  Bartholomeusz, C ^a,b   Itamochi, H ^a   Nitta, M ^c   Saya, H ^c   Ginsberg, M H ^d   Ueno, N T ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Adenovirus type 5 E1A; ERK; Ovarian neoplasms; PEA15; Proliferation

Indexed keywords

E1A PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1;

ADENOVIRUS 5; ANCHORAGE INDEPENDENT GROWTH; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CARCINOGENICITY; CELL LINE; CELL NUCLEUS; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; CYTOPLASM; DNA SYNTHESIS; ENZYME ACTIVATION; ENZYME INHIBITION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UPREGULATION; VIRUS GENE;

ADENOVIRUS E1A PROTEINS; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; CELL PROLIFERATION; CYTOPLASM; DNA; DOWN-REGULATION; ENZYME ACTIVATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSCOPY, FLUORESCENCE; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; RECEPTOR, ERBB-2; RNA, SMALL INTERFERING; TIME FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; UP-REGULATION;

HUMAN ADENOVIRUS TYPE 5;

EID: 30044450499     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1209014     Document Type: Article

References (60)

1. Araujo H, Danziger N, Cordier J, Glowinski J, Chneiweiss H. (1993). J Biol Chem 268: 5911-5920.
2. Bera TK, Guzman RC, Miyamoto S, Panda DK, Sasaki M, Hanyu K et al. (1994). Proc Natl Acad Sci USA 91: 9789-9793.
3. Byrd PJ, Grand RJ, Gallimore PH. (1988). Oncogene 2: 477-484.
4. Chang JY, Xia W, Shao R, Sorgi F, Hortobagyi GN, Huang L et al. (1997). Oncogene 14: 561-568.
5. Condorelli G, Trencia A, Vigliotta G, Perfetti A, Goglia U, Cassese A et al. (2002). J Biol Chem 277: 11013-11018.
6. Condorelli G, Vigliotta G, Cafieri A, Trencia A, Andalo P, Oriente F et al. (1999). Oncogene 18: 4409-4415.
7. Condorelli G, Vigliotta G, Iavarone C, Caruso M, Tocchetti CG, Andreozzi F et al. (1998). EMBO J 17: 3858-3866.
8. Danziger N, Yokoyama M, Jay T, Cordier J, Glowinski J, Chneiweiss H. (1995). J Neurochem 64: 1016-1025.
9. Debbas M, White E. (1993). Genes Dev 7: 546-554.
10. Deng J, Xia W, Hung MC. (1998). Oncogene 17: 2167-2175.
11. Douglas JL, Gopalakrishnan S, Quinlan MP. (1991). Oncogene 6: 2093-2103.
12. Estelles A, Charlton CA, Blau HM. (1999). Dev Biol 216: 16-28.
13. Estelles A, Yokoyama M, Nothias F, Vincent JD, Glowinski J, Vernier P et al. (1996). J Biol Chem 271: 14800-14806.
14. Formstecher E, Ramos JW, Fauquet M, Calderwood DA, Hsieh JC, Canton B et al. (2001). Dev Cell 1: 239-250.
15. Freedman VH, Shin SI. (1974). Cell 3: 355-359.
16. Frisch SM. (1991). Proc Natl Acad Sci USA 88: 9077-9081.
17. Frisch SM. (1994). J Cell Biol 127: 1085-1096.
18. Frisch SM. (2004). Clin Cancer Res 10: 2905-2907.
19. Frisch SM, Dolter KE. (1995). Cancer Res 55: 5551-5555.
20. Frisch SM, Mymryk JS. (2002). Nat Rev Mol Cell Biol 3: 441-452.
21. Frisch SM, Reich R, Collier IE, Genrich LT, Martin G, Goldberg GI. (1990). Oncogene 5: 75-83.
22. Gaumont-Leclerc MF, Mukhopadhyay UK, Goumard S, Ferbeyre G. (2004). J Biol Chem 279: 46802-46809.
23. Gum R, Lengyel E, Juarez J, Chen JH, Sato H, Seiki M et al. (1996). J Biol Chem 271: 10672-10680.
24. Hao C, Beguinot F, Condorelli G, Trencia A, Van Meir EG, Yong VW et al. (2001). Cancer Res 61: 1162-1170.
25. Hortobagyi GN, Ueno NT, Xia WY, Zhang S, Wolf JK, Putnam JB et al. (2001). J Clin Oncol 19: 3422-3433.
26. Hwang S, Kuo WL, Cochran JF, Guzman RC, Tsukamoto T, Bandyopadhyay G et al. (1997). Genomics 42: 540-542.
27. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E et al. (2004). CA Cancer J Clin 54: 8-29.
28. Krueger J, Chou FL, Glading A, Schaefer E, Ginsberg MH. (2005). Mol Biol Cell 8: 3552-3561.
29. Kubes M, Cordier J, Glowinski J, Girault JA, Chneiweiss H. (1998). J Neurochem 71: 1307-1314.
30. Land H, Parada LF, Weinberg RA. (1983). Nature 304: 596-602.
31. Lee WP, Liao Y, Robinson D, Rung HJ, Liu ET, Hung MC. (1999). Mol Cell Biol 19: 8075-8082.
32. Mymryk JS. (1996). Oncogene 13: 1581-1589.
33. Nelson CC, Braithwaite AW, Silvestro M, Bellett AJ. (1990). Proc Natl Acad Sci USA 87: 8041-8045.
34. Pages G, Guerin S, Grall D, Bonino F, Smith A, Anjuere F et al. (1999). Science 286: 1374-1377.
35. Pages G, Lenormand P, L'Allemain G, Chambard JC, Meloche S, Pouyssegur J. (1993). Proc Natl Acad Sci USA 90: 8319-8323.
36. Ramos JW, Hughes PE, Renshaw MW, Schwartz MA, Formstecher E, Chneiweiss H et al. (2000). Mol Biol Cell 11: 2863-2872.
37. Rao L, Debbas M, Sabbatini P, Hockenbery D, Korsmeyer S, White E. (1992). Proc Natl Acad Sci USA 89: 7742-7746.
38. Renault F, Formstecher E, Callebaut I, Junier MP, Chneiweiss H. (2003). Biochem Pharmacol 66: 1581-1588.
39. Renganathan H, Vaidyanathan H, Knapinska A, Ramos JW. (2005). Biochem J May 26 (Epub ahead of print].
40. Ruley HE. (1983). Nature 304: 602-606.
41. Sebolt-Leopold JS, Dudley DT, Herrera R, Van Becelaere K, Wiland A, Gowan RC et al. (1999). Nat Med 5: 810-816.
42. Seger YR, Garcia-Cao M, Piccinin S, Cunsolo CL, Doglioni C, Blasco MA et al. (2002). Cancer Cell 2: 401-413.
43. Shao R, Karunagaran D, Zhou BP, Li K, Lo SS, Deng J et al. (1997). J Biol Chem 272: 32739-32742.
44. Shao R, Xia W, Hung MC. (2000). Cancer Res 60: 3123-3126.
45. Teodoro JG, Shore GC, Branton PE. (1995). Oncogene 11: 467-474.
46. Trencia A, Perfetti A, Cassese A, Vigliotta G, Miele C, Oriente F et al. (2003). Mol Cell Biol 23: 4511-4521.
47. Ueno NT, Bartholomeusz C, Herrmann JL, Estrov Z, Shao R, Andreeff M et al. (2000). Clin Cancer Res 6: 250-259.
48. Ueno NT, Yu D, Hung M-C. (1997). Oncogene 15: 953-960.
49. Whitehurst AW, Robinson FL, Moore MS, Cobb MH. (2004). J Biol Chem 279: 12840-12847.
50. Xu F, Yu Y, Le XF, Boyer C, Mills GB, Bast Jr RC. (1999). Clin Cancer Res 5: 3653-3660.
51. Yan DH, Chang LS, Hung MC. (1991). Oncogene 6: 343-345.
52. Yoo GH, Hung MC, Lopez-Berestein G, LaFollette S, Ensley JF, Carey M et al. (2001). Clin Cancer Res 7: 1237-1245.
53. Young KS, Weigel R, Hiebert S, Nevins JR. (1989). Mol Cell Biol 9: 3109-3113.
54. Yu D, Hamada J, Zhang H, Nicolson GL, Hung MC. (1992). Oncogene 7: 2263-2270.
55. Yu D, Matin A, Xia W, Sorgi F, Huang L, Hung MC. (1995). Oncogene 11: 1383-1388.
56. Yu D, Suen TC, Van DH, Chang LS, Hung MC. (1990). Proc Natl Acad Sci USA 87: 4499-4503.
57. Yu D, Wolf JK, Scanlon M, Price JE, Hung MC. (1993). Cancer Res 53: 891-898.
58. Yu DH, Scorsone K, Hung MC. (1991). Mol Cell Biol 11: 1745-1750.
59. Zang RY, Shi DR, Lu HJ, Cai SM, Lu DR, Zhang YJ et al. (2001). Int J Gynecol Cancer 11: 18-23.
60. Zhang Y, Yu D, Xia W, Hung MC. (1995). Oncogene 10: 1947-1954.